Staphylococcus aureus is a major human pathogen that is well known for its ability to develop resistance to antimicrobial therapies. Recent studies have identified a combination of β-lactam antibiotic and daptomycin (DAP) to be highly effective at killing single and multi-drug-resistant S. aureus. Of particular interest is this drug combination's efficiency with which it kills strains classified as DAP-resistant methicillin-resistant Staphylococcus aureus (DAP-R MRSA). The goals of the present study were two-fold: to provide a physiological profile of a DAP-R S. aureus strain undergoing beta-lactam treatment by observing changes in autolytic rate, susceptibility to lytic enzymes, levels of peptidoglycan O-acetylation, release of lipoteichoic acid, and localization of the major cellular autolysin Atl. Additionally, the manner by which β-lactam+DAP therapy was bactericidal was explored by examining cell viability and culture optical density in response to DAP+Nafcillin (NAF). The strains used in this study were a well-characterized DAP-R MRSA D712 and its isogenic DAP-Susceptible MRSA precursor (DAP-S MRSA) D592. Growth of DAP-S and DAP-R MRSA in the presence of the nafcillin increased whole cell and crude cell wall (CCW) autolysis.
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Without the support of the individuals mentioned here this thesis could not have been completed, and I am eternally grateful for everything they have done. However, a significant problem with antibiotic therapy is the emergence of resistance to a particular compound within the organism being treated. The gram-positive pathogen
Staphylococcus aureus is known to rapidly evolve resistance to novel antibiotics: in 1960-only one to two years after the introduction of methicillin--a penicillinase-resistant member of the β-lactam antibiotic family, methicillin-resistant Staphylococcus aureus (MRSA) strains began to emerge (1) .
Today, MRSA infections number approximately 75,000 annually (2). Treatment for MRSA bacteremia and infective endocarditis typically consists of antimicrobial monotherapy with vancomycin (VAN) or daptomycin (DAP) (3) . Treatment with VAN or DAP as first and second line treatments can in many cases lead to the emergence of resistance phenotypes (4), leaving practitioners with limited therapeutic options. The emergence of resistance phenotypes is a common and expected phenomenon. Traditional practice when treating resistant infections has been to change therapy to an antibiotic to which the organism remains susceptible; however, this inevitably leads to resistance evolving to the novel compound. Continued use ultimately leads to a dwindling arsenal of new antimicrobials with which to treat infections. One strategy to combat the emergence of drug resistance is to develop combination therapies that utilize currently available compounds to more effectively treat drug resistant infections. Although there is currently no approved combination therapy for the treatment of MRSA bacteremia it has been shown in a number of cases that a combination of an antistaphylococcal β-lactam and DAP is an extremely effective combination (4), having cleared infections that had persisted for up to three weeks surviving and developing resistance to vancomycin and daptomycin monotherapy (5) . Although the effectiveness of the β-lactam+DAP combination therapy is interesting in its own right it is especially fascinating that daptomycin resistant (DAP-R) strains exhibited a daptomycin susceptible (DAP-S) phenotype when challenged with this drug combination (4).
β-lactam Antibiotics
Penicillin, the most well known of the β-lactams, was discovered by Alexander Fleming in 1928. Following this discovery was a torrent of research that determined that strain, media, and culture conditions resulted in several penicillin derivatives (6), However, the presence of a characteristic "β-lactam" ring remained constant, hence the drug class name. Despite the initial efficacy of penicillin, resistant strains of S. aureus developed quickly, and within twenty years more than 80% of strains were found to be penicillin-resistant (7) . In response to increasing prevalence of penicillin-resistant strains, considerable work was put into developing penicillin derivatives that would remain effective. One highly successful derivative is methicillin, the first penicillinaseresistant β-lactam which was approved for clinical use in the United States in 1960 (6, 7) .
Synthesis of β-lactam derivatives has proven invaluable in modern medicine, however, natural product discovery has led to the development of compounds with notably different β-lactam rings. For example, cephalosporins possess an entirely different "βlactam nucleus" to that of penicillin (6-APA vs. 7-ACA, respectively), while carbapenems and monobactams are significantly different from both penicillin's 6-APA ring and the cephalosporin 7-ACA ring (6) .
β-lactam resistance can develop in several ways. Penicillin resistance is rooted in the secretion of penicillinase, an enzyme that breaks down penicillin. To combat penicillinase-based resistance, methicillin, a penicillinase-resistant β-lactam was introduced. Despite methicillin's initial effectiveness resistant strains were quickly found, some as early as the year of its clinical approval (1, 6, 7) . Although β-lactamases are an effective mechanism of resistance, they are not the only mechanism. Other critical sources of β-lactam resistance lie in the penicillin-binding proteins (PBPs), the binding target of β-lactams that are integral in the construction of the cell wall. S. aureus typically encodes four PBPs (PBP1-4). Methicillin resistance is rooted in the acquisition of Staphylococcal Chromosomal Cassette mec (SCCmec) which includes the mecA gene that encodes a fifth PBP, PBP2a-a PBP with low affinity for β-lactams allowing unperturbed cell wall synthesis in the presence of β-lactams (7) . Although the presence of PBP2a is pivotal in the development of β-lactam resistance, previous work has reinforced the important roles of other PBPs in the context of alternative therapies, demonstrating that β-lactams that selectively target PBP1 enhance DAP activity to a greater extent than those that non-selectively inhibit PBPs such as nafcillin (8) .
Daptomycin
Daptomycin is a 1.6 kDa anionic lipopeptide antibiotic that associates with Ca 2+ in its active form giving it a net positive charge. It is isolated from Streptomyces roseosporus and was approved for clinical use in 2004 (9, 10) . Current models for the DAP mechanism of action identifies the target of DAP as the cell membrane, where it binds phospatidylglycerol and aggregates, causing the leakage of ions, membrane depolarization, disruption of protein, DNA and RNA synthesis and ultimately cell death (9, 11) . To bind its target, DAP requires Ca 2+ , the binding of which results in conformational changes that account for membrane insertion and oligomerization potentially as a result of increased exposure of hydrophobic residues in the molecule (9) .
Daptomycin resistance is complex, involving a diverse range of genes ranging from those responsible for membrane lipid biosynthesis to cell wall regulation (12, 13) .
Interestingly, gain of function mutations in the gene mprF -responsible for synthesis of lysyl phosphatidylglycerol, a positively charged membrane phospholipid -have been found to be relatively common in clinical DAP-R isolates (14) . Due to the increased presence of positively charged phospholipids in clinical DAP-R strains a charge repulsion mechanism has been proposed as part of the DAP resistance phenotype, while for in vitro derived strains charge repulsion cannot always explain resistance (14) . Previous work has demonstrated that exposure to β-lactams results in increased DAP binding (4) suggesting that a decrease in cell surface positive charge is associated with β-lactam treatment. It is speculated that release of membrane-bound lipoteichoic acid (LTA), which is often modified with D-alanine, thereby increasing the overall net positive charge of the membrane, could play a role in the increased ability of DAP to bind its target. This is supported by research demonstrating the exceptionally increased binding ability of mammalian group IIa phosphpolipases A2, which are similarly charged and bind similar targets as DAP, to S. aureus strains with mutations in dltA, rendering them unable to add D-alanine to LTA (15) . Exposure to β-lactam antibiotics has been shown to cause the release of LTA from the cell membrane (16) ; however, this has yet to be directly demonstrated in a study examining this synergy. Further evidence for the significance of charge-based repulsion has been provided by Sakoulas et. al. (5) , where enhanced binding and killing due to host cationic defense peptides was observed upon treatment with sub-MIC concentrations of the β-lactam nafcillin (NAF).
Unlike β-lactam antibiotics that primarily cause cell lysis due to a weakened cell wall, DAP can be bactericidal without lysis (17) . When challenged with daptomycin, early exponential phase cells exhibit rapid loss of viability with little to no concomitant drop in optical density, implying a lack of lysis, which was further confirmed by electron microscopy (17) . Interestingly, previous work has demonstrated an ability of daptomycin to remain lethal against stationary-phase cultures. Although daptomycin does affect cell division machinery, and thus the cell wall (12, 17, 18) , it remains to be determined whether cells undergoing β-lactam+DAP therapy are preferentially killed by one antimicrobial mechanism or another.
Autolysins
Previous work has demonstrated that growth of MRSA in β-lactam-containing media causes whole cells to exhibit increased autolysis, and crude and purified cell wall preparations are more susceptible to degradation by lysozyme (17) . One potential source of increased autolysis could be a result of delocalization of the major cellular autolysin
Atl. In addition to charge-based repulsion, simple size exclusion is another potential source of DAP resistance. Previous studies of vancomycin-resistant strains have found that VAN resistance and DAP resistance are correlated with increased cell wall thickness (10) . It could be possible that delocalized Atl sufficiently weakens the cell wall and "opens" it to penetration by DAP molecules.
Autolysins, named for their capacity to cause rapid cell lysis unless tightly regulated are also commonly referred to as peptidoglycan hydrolases and play significant roles in the regulation of cell wall growth/turnover and the separation of daughter cells during cell division (19, 20) . AtlA is the most prominent peptidoglycan hydrolase in S.
aureus with implications in cell wall maintenance and cell division as well the initial stages of biofilm formation (19, 20) . AtlA is expressed as a 137.5 kDa pro-protein that is cleaved into four distinct parts, two of which are amidase and glucosaminidase domains that are responsible for much of the previously discussed function of Atl (20) . Loss of the atl gene has been shown to decrease the effectiveness of lytic antimicrobials such as β-lactams, due to the cell's inability to divide (21) . In addition to Atl, Sle1 is another important hydrolase involved in cell septation, although it has not been determined to be implicated in autolysis of S. aureus (22) .
In addition to autolysins, several antibacterial lytic enzymes are classified as peptidoglycan hydrolases, two of these enzymes are lysozyme and lysostaphin.
Lysozyme is an antimicrobial enzyme naturally produced by many organisms, and one of the most common sources of lysozyme is hen egg white (7) . Lysozyme targets the bond joining the N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) subunits of peptidoglycan (PGN) to cause rapid lysis, although many pathogenic organisms, S.
aureus included, are highly resistant to lysozyme. Currently, the O-acetylation of C-6 on NAM is proposed as the reason for this resistance, since many non-pathogenic organisms (Staphyococcus carnosus and Staphyococcus xylosus for example) lack O-acetyl groups (23, 24) . Lysostaphin is a potent lytic enzyme that is isolated from Staphylococcus simulans biovar staphylolyticus, and is effective against most species due to its targeting of the staphylococcal-specific pentaglycine cross-bridge that cross-links individual strands of PGN (7, 25, 26) .
Lipoteichoic Acid
The staphylococcal cell envelope consists primarily of PGN and teichoic acids (TAs) (27) . While PGN is well characterized, the functions of teichoic acids are not fully known (27) . Teichoic acids are of two types: wall teichoic acids (WTA) and lipoteichoic acids (LTA), and determining the specific function of each has been made complicated due to their multiple functions, several of which overlap (27) . LTA are embedded in the cell membrane and composed of a polyglycerolphosphate backbone, while WTA are covalently linked to cell wall PGN and composed of a polyribitolphosphate backbone (24, 27 ). An important modification to teichoic acids is D-alanylation, which occurs via proteins specified by the dlt operon. D-alanine serves a general function as a counterion to determine net anionic charge of a teichoic acid (24) . The dlt operon consists of four genes (dltABCD) that slightly overlap (24) . dltA and dltC encode Dcl and Dcp, respectively, while dltB encodes a transport protein and dltD a membrane protein.
Together, the general model of LTA D-alanylation consists of attachment of D-alanine to
Dcp by Dcl and transport to the extracellular surface through a channel (DltB), with DltD serving as a binding site for both Dcp and Dcl (24) . Interestingly, it has been determined that D-alanine esters on WTA are derived from LTA, however, the process by which this happens is not clear (24) .
In B. subtilis, inactivation of dltABC or D results in both wall and lipoteichoic acids lacking D-alanine; additionally, strains deficient in D-alanine exhibited increased autolysis and methicillin sensitivity (24) . S. aureus dlt mutants are unable to alanylate their teichoic acids and exhibit increased susceptibility to cationic host defense peptides due to the increased net anionic charge on TAs (24) . D-alanyl TAs have had a multitude of functions ascribed to them depending on the species. These functions include general cation homeostasis, cell wall electrochemical composition, protein folding, antibiotic resistance, and biofilm formation (24) . As previously mentioned, D-alanine can migrate between LTA and WTA with relative ease, and it has been proposed that the location of D-alanine may serve as a signal for proteins that require specific ionic environments to function (24) . One class of proteins that fit this description are autolysins, thus, a loss of LTA leads to hypo-alanylated WTA, which could lead to autolysin delocalization.
Specific Aims and Hypotheses
Cell wall physiology and autolytic properties are essential knowledge when understanding mechanisms of resistance and DAP-R cells are relatively uncharacterized in the context of β-lactam+DAP therapy. To remedy this, we aimed to document the physiological changes in the bacterial cell wall and cell wall-associated elements pre-and post-β-lactam treatment. We hypothesized that growth in media containing NAF would result in a wide range of effects including increased rates of autolysis of whole cells and crude cell walls in addition to cells with walls with a decreased level of O-acetylation that are more prone to lysis by lytic enzymes. In addition, we expected to see increased liberation of LTA into the culture medium, a phenomenon that may be implicated in increased autolysis due to delocalization of the major cellular autolysin Atl.
Our second objective was to examine the loss of cell viability in response to β-lactam+DAP treatment. We expected that exponentially growing cells would exhibit cell lysis as the main mode of killing during β-lactam+DAP therapy, likely due to the compounding physiological defects in the cell wall induced by β-lactams as well as daptomycin. We expected that this combination would not remain effective against stationary-phase cells, despite DAP's potential to kill stationary-phase cells by depolarizing the membrane and disrupting protein, DNA, and RNA synthesis due to an inability to reach and/or bind its target at the cell membrane. Cells were then harvested by centrifugation at 4°C for 10 minutes at 13,000 xg and washed twice in an excess cold 0.9% NaCl for 10 minutes. Following washing, pellets were resuspended in cold 0.9% NaCl and mechanically disrupted using 0.1mm glass beads in five two minute intervals for a total of ten minutes of disruption. Glass beads were separated from disrupted cell material by vacuum filtration through a 40µm filter, and the cell fragments transferred to centrifuge tubes for harvesting (as done previously).
After harvesting, a portion of the crude cell wall fraction (CCW) was resuspended in cold dH2O and saved for use in CCW autolysis experiments. The remaining material was washed twice in cold dH2O before boiling in 2% SDS for 30 minutes. After boiling in SDS, peptidoglycan was harvested by centrifugation at 20°C and then washed twice in room temperature dH2O. After washing, remaining material was incubated overnight at 37°C in 0.1M Tris-HCl solution (pH 6.8) containing 100 µg/ml Proteinase K. Following proteinase K treatment the solution was harvested by centrifugation for 10 minutes at 13,000 xg, washed four times in room temperature dH2O to remove as much left over SDS as possible, and then lyophilized and saved as purified cell wall (PCW) fragments.
CCW Autolysis
CCWs obtained from mechanical disruption using glass beads were diluted in 0.05M K2HPO4 buffer pH 7.2 to OD580 0.4-0.6, incubated at 37°C for four hours and the OD580 was monitored every thirty minutes. Data are presented as a percentage of the initial OD.
PCW Lysis
Lyophilized PCWs were resuspended in Tris-HCl pH 7.5 to OD580 0.5-0.6 and incubated with 100 µg/ml lysozyme at 37°C for four hours and the OD580 was monitored every thirty minutes. A lysostaphin lysis assay was carried out alongside the lysozyme assay with a few modifications: a concentration of 5 µg/ml lysostaphin was used, and OD620 was monitored instead of OD580 in accordance with established lysostaphin lysis assay protocols (25) . Data are presented as a percentage of the initial OD.
Degree of O-acetylation
Taking care to keep pH below 7.0 during the isolation of PCW ensures that the highly alkali-labile O-acetyl group remains present on the wall. To liberate O-acetyl groups from PCW, lyophilized PCW fragments (5-10mg) were incubated in either 400µl
80mM NaOH or pH 6.8 PBS (negative control) for 3 hours at 30°C. After incubation NaOH was neutralized with an appropriate amount of H2SO4. Following centrifugation for 10 minutes at 13,000 xg the supernatant was harvested to determine the degree of Oacetylation, which was analyzed using the K-ACET Acetic Acid Analysis Kit (Megazyme Inc.). Addition of reagents was carried out according to kit protocol. Oacetyl groups were quantified against a standard curve constructed using several concentrations of acetic acid standard provided in the kit (0.1 mg/mL), and presented as nano-moles of acetic acid per mg of dry PCW.
Quantification of Released Lipoteichoic Acid
In order to quantify the amount of LTA released due to exposure to β-lactams, bacterial supernatants were analyzed via ELISA as described by Van Langevelde et al. 
% of Initial OD600
CHAPTER III
RESULTS

Growth in the Presence of Nafcillin Increases Whole Cell and CCW Autolysis Rates
Both whole cell and crude cell wall preparations from cells grown in the presence of nafcillin autolyse at a faster rate ( Fig. 1, 2) . While unexposed CCW preparations fail to autolyze almost entirely, losing only about 10% of the initial OD, CCW of exposed cells clear to approximately 50% and 35% in D712 and D592 respectively. 
Crude cell wall autolysis of S. aureus strains D592 and D712 unexposed or exposed to 20μg/ml NAF represented as percent decrease of OD over 4 hours. Significance was determined by K-S test of NAF treated vs. NAF untreated strains, in each case D > Dα
Growth in the Presence of NAF Sensitizes PCW to Lytic Enzymes Treatment with β-lactam antibiotics is likely to affect the composition of the overall cell wall with respect to cross-linking or peptidoglycan chain length. To evaluate cell wall integrity crude cell wall preparations were further purified by boiling in 2% SDS and incubation with proteinase K. Similar to whole cell and CCW autolysis studies, NAF+ purified cell wall preparations are much more susceptible to degradation by lytic enzymes (lysozyme and lysostaphin) than untreated preparations ( Fig. 3, 4) .
Interestingly, untreated D712 displays slight lysostaphin resistance (Fig. 4) ; however, this resistance was negated after growth in NAF. 
Purified cell wall lysis with lysozyme (100μg/ml) in S. aureus strains D592 and D712 unexposed or exposed to 20μg/ml NAF. Data represented as percent decrease in initial OD. Significance was determined by K-S test of NAF treated vs. NAF untreated strains, in each case D > Dα
Purified cell wall lysis with lysostaphin (5μg/ml) in S. aureus strains D592 and D712 unexposed or exposed to 20μg/ml NAF. Data represented as percent decrease in initial OD. Significance was determined by K-S test of NAF treated vs. NAF untreated strains, in each case D > Dα
O-acetylation of Cell Walls is not Significantly Affected by Growth in NAF
O-acetylation has previously been shown to aid in immune system evasion (23) .
Estimation of O-acetylation levels was performed using the MegaZyme acetic acid assay kit as reported elsewhere (30) and the total released acetate is reported. While Oacetylation levels do vary by about 7% between treated and untreated strains of D712 this trend does not hold true for D592 ( Fig. 5 ). In addition, while high levels of O-acetylation have been demonstrated in previous studies (23) to contribute to lysozyme resistance, we did not consider this relatively small difference a to be a significant source of increased lysozyme resistance, and did not pursue it further. 
LTA Release is Increased in Response to NAF Treatment
To determine and quantify the amount of LTA released into culture medium ELISA was performed. Cells grown in sub-MIC concentrations of nafcillin exhibited an increase in the amount of LTA released into culture medium by an average of approximately 120 ng/ml (Fig. 6) , interestingly, significance was detected in strain D712 via a paired sample t-test but not strain D592. 
Growth in NAF Alters Atl Processing
S. aureus strains grown in nafcillin were hypothesized to undergo a delocalization of the major cellular autolysin Atl. A method was developed to infer the location of Atl in the cell wall during exponential phase. If increased rates of autolysis upon beta lactam treatment are due to delocalized surface autolysins, and not an increased or decreased amount of enzyme, there should be no significant difference in autolysis rates between treatments within the same strain. Cells were harvested in exponential phase (OD600 0.4-0.5) and subjected to freeze/thaw extraction. To verify lytic activity of extracts each extract was subjected to zymographic analysis (Fig 7) . 10 μl of freeze/thaw extract from each treatment was electrophoresed on a polyacrylamide gel containing 0.2% lyophilized
Micrococcus luteus cells and clearing of stained cells was observed. Following confirmation of lytic activity the protein concentration of each extract was determined by
Bradford assay (Fig. 8) , and suspensions of M. luteus were challenged with equivalent amounts of protein from each extract. Differences in band intensity observed during zymographic analysis are due to differences in total protein concentration of extracts.
Differences in protein extracted per strain and treatment may be a result of differences in extraction efficiency. Both 1 µg (data not shown) and 10 μg ( Fig. 9 ) treatments display little to no activity in suspension.
Figure 7. Zymographic Analysis
Zymographic analysis for verification of lytic activity of freeze/thaw protein extracts. Zymogram was prepared pre-Bradford assay to verify activity of extracts. 10 µl of each extract was added per well; differences in band intensity are due to different overall protein concentration of extracts. NAF+DAP treatment are dying preferentially to one antimicrobial mechanism, its potency was tested against exponential and early stationary phase cells. Exponential phase cells exhibited lysis as a result of NAF+DAP treatment as is indicated by the dramatic decrease in optical density upon addition of DAP ( Fig. 9 ), while those untreated with DAP continue to grow normally. Stationary phase cells growing in the presence of OD600 NAF were largely unaffected by DAP, and in some cases continued to grow (D712+NAF+DAP) (Fig. 10 ). Daptomycin+Nafcillin is an extremely potent combination with well documented effectiveness (4) . While the potency of this combination has been known for some time, its mechanism of action has remained unclear. A necessary first step in fully elucidating the mechanism of this antibacterial combination is knowledge of multiple physiological markers present in the bacterial cell wall when undergoing beta-lactam therapy to provide clues for future research.
Here we have examined a number of physiological traits present in DAP-R S.
aureus cells to provide a more complete physiological profile of the DAP-R phenotype in response to β-lactam treatment. Whole cells and crude cell wall preparations become much more susceptible to autolysis upon growth in β-lactam containing media, suggesting an overall weakened cell wall. Cell wall disruption by β-lactams is due to interruption of the PBPs, and in S. aureus a significant degree of cell wall integrity is derived from cross-linking. Cross-linking in MRSA has previously been shown to be decreased due to inhibition of PBP4 (17, 31) , a phenomenon exhibited by PBP non-specific β-lactams such as NAF. The ability of lysostaphin to rapidly lyse PCW from cells grown in the presence of NAF supports the presence of hypo-crosslinked cell walls.
Lysostaphin targets the pentaglycine cross-bridge of S. aureus to significantly disrupt cell wall integrity and cause lysis. Interestingly, we detected notable lysostaphin resistance in strain D712 when grown in the absence of NAF. Lysostaphin resistance is not well understood, however, lysostaphin resistance A (lyrA) has been determined as a major factor (32) . Interestingly, lyrA does not significantly modify the pentaglycine crossbridge to produce an un-bindable substrate for lysostaphin (32) . Should this phenotype be pursued in future work, sequencing is first required to examine this strain for any lyrA mutations, along with other mutations that may be compounding factors such as femAB, which produces significant alterations in pentaglycine crossbridges (32) . PCW. If we wish to explore this phenomenon further, a necessary next step will be to extract O-acetyl groups from PCW samples as done when determining O-acetylation levels and treat these newly O-acetyl group free PCW samples with lysozyme. In addition, further work should be done to definitively determine O-acetylation levels by using previously established methods (28) .
An additional source of disrupted cell wall integrity could lie in inhibition of PBP1. Recent work suggests that β-lactams that selectively bind PBP1 potentiate DAP to a greater extent than those that specifically target other PBPs (6) . PBP1 of S. aureus is homologous to PBP3 of E. coli, which interacts with important cell division machinery (6) , and recent studies suggest that interruption of PBP1 activity is implicated in construction of aberrant cell walls (33) . NAF is a nonselective β-lactam and exhibits a degree of binding to all PBPs (33) , thus, in addition to inactivation of PBP2. Repetition of these experiments using β-lactams specific for certain PBPs may help clarify this phenomenon.
We observed a significant increase in the release of LTA into culture medium from cells undergoing growth in β-lactam containing media. Teichoic acids play numerous roles in the cell and their full function is not yet understood, however, previous work has determined that, while the absence of either LTA or WTA is non-lethal, the cell cannot survive the absence of both (27) . LTA and WTA are implicated in many cellular processes, and an important modification for that function is the D-alanylation of LTA (24) . Enhanced DAP binding has already been observed upon β-lactam treatment, and the exact mechanism by which this happens has yet to be determined (4). One suggestion for increased DAP binding in the presence of nafcillin is that the release of D-alanyl LTA results in a less positive membrane environment that lessens the impact of lysylphosphatidylglycerol in a charge repulsion mechanism (4).
We aimed to examine the localization Atl as a possible source of increased whole cell and crude cell wall autolysis. In addition to autolysis assays, we extracted Atl from cell walls as bulk protein extract by the freeze/thaw method. When M. luteus cells were exposed to equivalent amounts of cell wall protein extracts we hoped to observe similar lysis rates, implying that the fraction of Atl in any given treatment is similar, and that the increased rates of autolysis are not due to an increase in Atl number or activity, but rather could be due to the location of the enzyme. However, we did not observe any degree of lysis in either 1 µg or 10 µg treatments, which may be due to the amount of protein used in the assay. While cells also fail to lyse when exposed to 10 µg of extracted protein, there are slightly more pronounced differences. This particular experiment needs to be repeated with higher concentrations of extracted protein to fully determine if there is any significant difference in cell wall protein extracts of these strains when treated with NAF.
Atl is a tightly regulated enzyme due to its ability to degrade peptidoglycan, and it is likely that delocalized and unregulated Atl activity could cause significant weakening of the cell wall. D-alanyl WTA has been proposed as a method of Atl sequestration. As reported earlier, previous work has determined that D-alanine on WTA are derived from LTA. Earlier studies have suggested that the ease with which D-alanine moves throughout the envelope could provide an essential environment for proteins that require specific ionic conditions, some of which are autolysins (24) . If D-alanine plays a DAP has been previously shown to be able to kill without lysis, demonstrating an ability to kill stationary phase cells (17) . We aimed to determine the main mode of killing by experiments similar to those done in previous work (4) on stationary phase cells exposed to this drug combination.
Future Directions
Given the complex nature of DAP resistance it is unlikely for the phenotype to be completely understood, however, the work done for this thesis could support several areas of future work. Avenues for future research could involve examination of the resistance of PCW to lysozyme in the apparent absence of O-acetyl groups. As The inferential process used here to determine Atl localization is imperfect, and definitive confirmation of delocalized Atl requires additional techniques. One way to support this work is through the use of qPCR to determine if the Atl gene is up/down regulated upon beta-lactam treatment. Similar levels of transcription among strains growing exposed and unexposed to NAF would support the data presented here. In addition to qPCR, construction of a fluorescent protein labeled Atl strain for direct microscopic visualization is essential, however, while this process is possible, it may be prohibitively cost or time-consuming. What also may be possible is to design an immunofluorescent system using monoclonal antibodies specific to the amidase and glucosaminadase domains of Atl. Recent work has proposed the creation and use of monoclonal antibodies to the glucosaminidase domain to disrupt MRSA cell growth during osteomyelitis (34) . Visualization of Atl during beta-lactam treatment is a necessary next step in elucidation of this mechanism.
Conclusions
Daptomycin resistance remains a complex problem with several genes implicated and significant differences among those strains deriving resistance in vitro versus those in vivo. Despite this complexity here we have provided clarification of the physiological profile of an in vivo-derived DAP-R strain and its isogenic DAP-S precursor undergoing beta-lactam therapy. Specifically, we have found that Growth of DAP-S and DAP-R MRSA in the presence of the nafcillin increases whole cell and crude cell wall (CCW) autolysis, and Growth in NAF increases susceptibility to lysozyme and lysostaphin.
These effects are likely due to an overall weaker cell wall. Interestingly, increases in PCW susceptibility to lysozyme appear to be independent of the levels of O-acetylation.
In addition, we found apparent alteration in Atl processing, and observed NAF+DAP to 
